P929: IXAZOMIB AND DARATUMUMAB WITHOUT DEXAMETHASONE (I-DARA) IN ELDERLY FRAIL RELAPSING MYELOMA (RRMM) PATIENTS: RESULTS OF THE PHASE 2 STUDY IFM 2018-02 OF THE INTERGROUPE FRANCO...

por Macro, M., Touzeau, C., Mariette, C., Manier, S., Brechignac, S., Vincent, L., Hebraud, B., Decaux, O., Schulmann, S., Lenoir, C., Godmer, P., Farge, A., Peyro Saint Paul, L., Parienti, J.-J., Leleu, X.
Publicado 2022

Peg-IFNα/ribavirin/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24

por Saadoun, David, Resche Rigon, M, Thibault, V, Longuet, M, Pol, S, Blanc, F, Pialoux, G, Karras, A, Bazin-Karra, D, Cazorla, C, Vittecoq, D, Musset, L, Decaux, O, Ziza, J M, Lambotte, O, Cacoub, Patrice
Publicado 2014

B01 VENETOCLAX TARGETED THERAPY in AL AMYLOIDOSIS PATIENTS: A RETROSPECTIVE ANALYSIS FROM THE FRENCH AMYLOIDOSIS NETWORK

por Roussel, M., Pirotte, M., Gounot, R., Queru, K., Rizzo, O., Royer, B., Harel, S., Desport, E., Huart, A., Niault, M., Karlin, L., Decaux, O., Chalopin, T., Carpentier, B., Macro, M., Vignon, M., Chalayer, E., Stoppa, AM., Bridoux, F., Jaccard, A.
Publicado 2023

P904: CILTACABTAGENE AUTOLEUCEL VS TREATMENTS FROM REAL-WORLD CLINICAL PRACTICE FOR TRIPLE CLASS EXPOSED PATIENTS WITH MULTIPLE MYELOMA: ADJUSTED COMPARISONS BASED ON CARTITUDE-1 A...

por Decaux, O., Hulin, C., Perrot, A., Macro, M., Frenzel, L., Diels, J., Perualila, N. J., Ghilotti, F., Haefliger, B., Goldsztajn, E., Vernet, S., Thevenon, J., Willaime, M., Texier, N., Schecter, J. M., Madduri, D., Jackson, C., Valluri, S., Moreau, P.
Publicado 2022

Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST trial

por Bahlis, N J, Corso, A, Mugge, L-O, Shen, Z-X, Desjardins, P, Stoppa, A-M, Decaux, O, de Revel, T, Granell, M, Marit, G, Nahi, H, Demuynck, H, Huang, S-Y, Basu, S, Guthrie, T H, Ervin-Haynes, A, Marek, J, Chen, G, Facon, T
Publicado 2017

P956: EMMY COHORT: MANAGEMENT OF NEWLY DIAGNOSED OR RELAPSED/ REFRACTORY MULTIPLE MYELOMA IN PATIENTS AGED OF 80 YEARS AND OVER

por Macro, M., Decaux, O., Perrot, A., Royer, B., Chretien, M., Belhadj, K., Mohty, M., Frenzel, L., Leleu, X., Dib, M., Allangba, O., Zunic, P., Botoc, I., Malfuson, J., Moreau, P., Garlantazec, R., Texier, N., Germain, R., Deal, C., Hulin, C.
Publicado 2022

P955: CARFILZOMIB IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: THE REAL-LIFE EXPERIENCE OF EMMY

por Hulin, C., Macro, M., Perrot, A., Royer, B., Caillot, D., Belhadj, K., Frenzel, L., Benramdane, R., Demarquette, H., Bareau, B., Darre, S., Calmettes, C., Le Calloch, R., Bouketouche, M., Laribi, K., Texier, N., Willaime, M., Deal, C., Moreau, P., Decaux, O.
Publicado 2022

P891: IXAZOMIB, POMALIDOMIDE AND DEXAMETHASONE (IXPD) IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) CHARACTERIZED WITH HIGH-RISK CYTOGENETICS. IFM 2014-01

por Bobin, A., Manier, S., De Keizer, J., Karlin, L., Perrot, A., Hulin, C., Caillot, D., Mariette, C., Lenain, P., Richez, V., Tiab, M., Touzeau, C., Jaccard, A., Decaux, O., Araujo, C., Belhadj, K., Benboubker, L., Déal, C., Macro, M., Vincent, L., Arnulf, B., Bareau, B., Braun, T., Calmettes, C., mamoun, D., Zerazhi, H., Demarquette, H., Feugier, P., Fohrer-sonntag, C., Godet, S., Petillon, M.-O., Avet-Loiseau, H., Leleu, X.
Publicado 2022